1. Signaling Pathways
  2. Others
  3. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W099730R
    Bemotrizinol (Standard)
    Bemotrizinol (Standard) is the analytical standard of Bemotrizinol. This product is intended for research and analytical applications. Bemotrizinol (Tinosorb S), an ultraviolet (UV) filter, has been shown to accept atomic oxygen generated by N-oxide photodeoxygenation.
    Bemotrizinol (Standard)
  • HY-150156
    Anti-inflammatory agent 32
    99.52%
    Anti-inflammatory agent 32 is a chalcone derivative with anti-inflammatory activity. Anti-inflammatory agent 32 can be used for the research of inflammatory bowel disease.
    Anti-inflammatory agent 32
  • HY-A0211
    Carphenazine
    99.16%
    Carphenazine is a phenothiazine antipsychotic agent. Carphenazine can be used for researching chronic schizophrenic psychoses.
    Carphenazine
  • HY-B1032R
    Dropropizine (Standard)
    Dropropizine (Standard) is the analytical standard of Dropropizine. This product is intended for research and analytical applications. Dropropizine ((±)-Dropropizine) is a peripheral antitussive agent that acts by inhibiting cough reflex through its action on the peripheral receptors and their afferent conductors.
    Dropropizine (Standard)
  • HY-W190956
    (S,R,S)-AHPC-PEG4-acid
    98.26%
    (S,R,S)-AHPC-PEG4-acid is a synthetic PROTAC ligand that binds the E3 ligase ligand to the PEG4 arm, thereby enhancing PROTAC drug research and discovery.
    (S,R,S)-AHPC-PEG4-acid
  • HY-116849
    LY 181984
    LY181984 is a compound in a series of orally active diarylsulfonylureas. LY181984 shows antitumor activity.
    LY 181984
  • HY-W276106
    KM02894
    99.31%
    KM02894 is an inhibitor of glutamate release. Cancer cells release high levels of glutamate, which disrupts normal bone turnover and may lead to cancer-induced bone pain. KM02894 can be used for cancer related research.
    KM02894
  • HY-148528
    SC-VC-PAB-N-Me-L-Ala-Maytansinol
    98.66%
    SC-VC-PAB-N-Me-L-Ala-Maytansinol (compound B1) can be used to synthesis MCC-Maytansinoid A. SC-VC-PAB-N-Me-L-Ala-Maytansinol can be used as a control compound for the cancer research.
    SC-VC-PAB-N-Me-L-Ala-Maytansinol
  • HY-100013
    2-PCCA
    Agonist
    2-PCCA is a racemic form of the GPR88 receptor agonist, and inhibits GPR88-mediated cAMP production, with an EC50 of 116 nM in HEK293 cells.
    2-PCCA
  • HY-159251
    C19 3'-Sulfo galactosylceramide (d18:1/19:0)
    98%
    C19 3'-Sulfo Galactosylceramide (d18:1/19:0) is a synthetic derivative of sulfatide.
    C19 3'-Sulfo galactosylceramide (d18:1/19:0)
  • HY-106535
    Valbilan
    98.0%
    Valbilan (Febuprol) is a choleretic agent. Valbilan exhibits spasmolytic and lipid lowering effects.
    Valbilan
  • HY-U00101
    Octazamide
    99.07%
    Octazamide (ICI-US 457) is an analgesic agent.
    Octazamide
  • HY-B1015
    Etosalamide
    98.93%
    Etosalamide (Ethosalamide) is an antipyretic and analgesic agent. Etosalamide has anti-inflammatory activity and can be used for allergic disease research.
    Etosalamide
  • HY-163642
    TNF-α agonistic 1
    98.37%
    TNF-α agonistic 1 (compound 22a) can repolarize tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) from the M2 phenotype to the M1 anti-tumor phenotype.
    TNF-α agonistic 1
  • HY-W013160R
    Bis(2-ethylhexyl) terephthalate (Standard)
    Bis(2-ethylhexyl) terephthalate (Standard) is the analytical standard of Bis(2-ethylhexyl) terephthalate. This product is intended for research and analytical applications.
    Bis(2-ethylhexyl) terephthalate (Standard)
  • HY-147064
    DL-4-Hydroxy-2-ketoglutarate lithium
    DL-4-Hydroxy-2-ketoglutarate lithium is the substrate of 4-hydroxy-2-oxoglutarate aldolase (HOGA). DL-4-Hydroxy-2-ketoglutarate lithium can be cleaved by HOGA to produce pyruvate and glyoxylate.
    DL-4-Hydroxy-2-ketoglutarate lithium
  • HY-W923355
    1,2,3-Trieicosapentaenoyl glycerol
    99.9%
    1,2,3-Trieicosapentaenoyl glycerol (EPA-TG) is a glycerol ester that can be obtained by the reaction of polyunsaturated fatty acids or lower alkyl esters with glycerol catalyzed by alkoxide ions. After two intravenous injections of the EPA-TG emulsion into rabbits, the EPA content in plasma and platelet phospholipids increased markedly. In another study, by administering the EPA-TG emulsion, the production of leukotriene B4 by polymorphonuclear leukocytes in rabbits was reduced by 40%.
    1,2,3-Trieicosapentaenoyl glycerol
  • HY-158615
    STING18
    98.60%
    STING18 (Stimulator of interferon genes 18) is a compound that inhibits STING protein by utilizing a small molecule active site dimer, with good oral exposure, slow binding kinetics, and functional inhibitory activity on STING-mediated cytokine release.
    STING18
  • HY-165069
    N-Docosanoyl-D-erythro-sphingosylphosphorylcholine
    N-Docosanoyl-D-erythro-sphingosylphosphorylcholine (Sphingomyelin (d18:1 C22:0)) is a compound that appears in the plasma sphingolipid profile after chronic hepatitis C virus infection. The level of this substance in plasma is associated with hepatic steatosis and may be an independent factor of hepatic steatosis.
    N-Docosanoyl-D-erythro-sphingosylphosphorylcholine
  • HY-176998
    LP238-p
    LP238-p is a type of lipid molecule.
    LP238-p
Cat. No. Product Name / Synonyms Application Reactivity